Journal of the American College of Cardiology, ISSN 0735-1097, 06/2017, Volume 69, Issue 25, pp. 3042 - 3051
Abstract Background Acute heart failure (AHF) is a life-threatening disease requiring urgent treatment, including a recommendation for immediate initiation of...
Cardiovascular | Internal Medicine | B-type natriuretic peptide | Get With the Guidelines | emergency department | diuretics | prognosis | CARDIOLOGY | GUIDELINES | RISK SCORE | RELAX-AHF | EUROPEAN-SOCIETY | THERAPY | ADHERE | OUTCOMES | ASSOCIATION | PROGRAM | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | DYSPNEA | Furosemide - administration & dosage | Acute Disease | Diuretics - administration & dosage | Injections, Intravenous | Prospective Studies | Survival Rate - trends | Follow-Up Studies | Time-to-Treatment | Humans | Male | Heart Failure - drug therapy | Hospital Mortality - trends | Inpatients | Time Factors | Female | Registries | Aged | Odds Ratio | Heart Failure - mortality | Heart failure | Heart | Medical colleges | Patient outcomes | Cardiac patients | Mortality | Furosemide | Analysis | Intravenous administration | Enrollments | Medical services | Gender differences | Emergency medical care | Congestion | Emergency exits | Multivariate analysis | Patients | Confidence intervals | Studies | Variables | Hospitals | Diuretics | Emergency vehicles | Acute coronary syndromes | Cardiology | Heart diseases | Emergency medical services
Cardiovascular | Internal Medicine | B-type natriuretic peptide | Get With the Guidelines | emergency department | diuretics | prognosis | CARDIOLOGY | GUIDELINES | RISK SCORE | RELAX-AHF | EUROPEAN-SOCIETY | THERAPY | ADHERE | OUTCOMES | ASSOCIATION | PROGRAM | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | DYSPNEA | Furosemide - administration & dosage | Acute Disease | Diuretics - administration & dosage | Injections, Intravenous | Prospective Studies | Survival Rate - trends | Follow-Up Studies | Time-to-Treatment | Humans | Male | Heart Failure - drug therapy | Hospital Mortality - trends | Inpatients | Time Factors | Female | Registries | Aged | Odds Ratio | Heart Failure - mortality | Heart failure | Heart | Medical colleges | Patient outcomes | Cardiac patients | Mortality | Furosemide | Analysis | Intravenous administration | Enrollments | Medical services | Gender differences | Emergency medical care | Congestion | Emergency exits | Multivariate analysis | Patients | Confidence intervals | Studies | Variables | Hospitals | Diuretics | Emergency vehicles | Acute coronary syndromes | Cardiology | Heart diseases | Emergency medical services
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2017, Volume 10, Issue 12, pp. 1189 - 1198
Abstract Objectives The NIPPON (Nobori Dual Antiplatelet Therapy as Appropriate Duration) study was a multicenter randomized investigation of the...
Cardiovascular | dual antiplatelet therapy | net adverse clinical and cerebrovascular event(s) | biodegradable polymer | stent thrombosis | drug-eluting stent(s) | net adverse clinical and erebrovascular event(s) | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | RISK | PERCUTANEOUS CORONARY INTERVENTION | CLOPIDOGREL | PREDICTORS | CLINICAL-TRIALS | COMPLICATIONS | DURATION | Myocardial Infarction - mortality | Prospective Studies | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | Prosthesis Design | Aspirin - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Acute Coronary Syndrome - complications | Time Factors | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Stroke - mortality | Drug Therapy, Combination | Myocardial Infarction - etiology | Platelet Aggregation Inhibitors - adverse effects | Drug-Eluting Stents | Drug Administration Schedule | Japan | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Coronary Artery Disease - mortality | Ticlopidine - analogs & derivatives | Absorbable Implants | Stroke - etiology | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Coronary Artery Disease - complications | Acute Coronary Syndrome - diagnosis | Intention to Treat Analysis | Acute Coronary Syndrome - therapy | Clopidogrel | Polymers - chemistry | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects
Cardiovascular | dual antiplatelet therapy | net adverse clinical and cerebrovascular event(s) | biodegradable polymer | stent thrombosis | drug-eluting stent(s) | net adverse clinical and erebrovascular event(s) | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | RISK | PERCUTANEOUS CORONARY INTERVENTION | CLOPIDOGREL | PREDICTORS | CLINICAL-TRIALS | COMPLICATIONS | DURATION | Myocardial Infarction - mortality | Prospective Studies | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | Prosthesis Design | Aspirin - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Acute Coronary Syndrome - complications | Time Factors | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Stroke - mortality | Drug Therapy, Combination | Myocardial Infarction - etiology | Platelet Aggregation Inhibitors - adverse effects | Drug-Eluting Stents | Drug Administration Schedule | Japan | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Coronary Artery Disease - mortality | Ticlopidine - analogs & derivatives | Absorbable Implants | Stroke - etiology | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Coronary Artery Disease - complications | Acute Coronary Syndrome - diagnosis | Intention to Treat Analysis | Acute Coronary Syndrome - therapy | Clopidogrel | Polymers - chemistry | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 4, pp. 822 - 829
Purpose To determine whether adding intraluminal brachytherapy (ILBT) to definitive radiation therapy (RT) for unresectable biliary tract cancer has a positive...
Radiology | Hematology, Oncology and Palliative Medicine | IRRADIATION | EXTERNAL-BEAM RADIOTHERAPY | ONCOLOGY | BILE-DUCT CARCINOMA | IR-192 BRACHYTHERAPY | CHEMORADIATION | EXTRAHEPATIC CHOLANGIOCARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Brachytherapy - mortality | Humans | Japan | Middle Aged | Brachytherapy - methods | Male | Survival Rate | Treatment Outcome | Biliary Tract Neoplasms - mortality | Disease-Free Survival | Propensity Score | Biliary Tract Neoplasms - radiotherapy | Analysis of Variance | Matched-Pair Analysis | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Databases, Factual | Medical colleges | Radiology, Medical | Radioisotope brachytherapy | Nuclear radiation | Analysis | Index Medicus | PATIENTS | JAUNDICE | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | BILIARY TRACT | TOXICITY | STANDARD OF LIVING | BRACHYTHERAPY | CHEMOTHERAPY | SENSITIVITY ANALYSIS
Radiology | Hematology, Oncology and Palliative Medicine | IRRADIATION | EXTERNAL-BEAM RADIOTHERAPY | ONCOLOGY | BILE-DUCT CARCINOMA | IR-192 BRACHYTHERAPY | CHEMORADIATION | EXTRAHEPATIC CHOLANGIOCARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Brachytherapy - mortality | Humans | Japan | Middle Aged | Brachytherapy - methods | Male | Survival Rate | Treatment Outcome | Biliary Tract Neoplasms - mortality | Disease-Free Survival | Propensity Score | Biliary Tract Neoplasms - radiotherapy | Analysis of Variance | Matched-Pair Analysis | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Databases, Factual | Medical colleges | Radiology, Medical | Radioisotope brachytherapy | Nuclear radiation | Analysis | Index Medicus | PATIENTS | JAUNDICE | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | BILIARY TRACT | TOXICITY | STANDARD OF LIVING | BRACHYTHERAPY | CHEMOTHERAPY | SENSITIVITY ANALYSIS
Journal Article
Journal of Cardiology, ISSN 0914-5087, 2015, Volume 67, Issue 5, pp. 406 - 411
Abstract Background Although hyponatremia on admission is a predictor of poor prognosis in acute heart failure (AHF) patients, little is known about the...
Cardiovascular | Hyponatremia | Prognosis | Acute heart failure | DIAGNOSIS | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | ADMISSION | INTRAVENOUS MILRINONE | SERUM SODIUM CONCENTRATION | CLINICAL-OUTCOMES | Acute Disease | Age Factors | Hospital Mortality | Humans | Male | Antidiuretic Hormone Receptor Antagonists - therapeutic use | Hyponatremia - mortality | Heart Failure - therapy | Benzazepines - therapeutic use | Sex Factors | Female | Aged | Retrospective Studies | Hyponatremia - therapy | Heart Failure - mortality | Myocardial Ischemia - epidemiology
Cardiovascular | Hyponatremia | Prognosis | Acute heart failure | DIAGNOSIS | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | ADMISSION | INTRAVENOUS MILRINONE | SERUM SODIUM CONCENTRATION | CLINICAL-OUTCOMES | Acute Disease | Age Factors | Hospital Mortality | Humans | Male | Antidiuretic Hormone Receptor Antagonists - therapeutic use | Hyponatremia - mortality | Heart Failure - therapy | Benzazepines - therapeutic use | Sex Factors | Female | Aged | Retrospective Studies | Hyponatremia - therapy | Heart Failure - mortality | Myocardial Ischemia - epidemiology
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 3, pp. 795 - 797
Bullous pemphigoid, the most common autoimmune blistering disease, is characterized by an autoimmune response to a component of hemidesmosomes within the...
Pulmonary/Respiratory | LUNG | HEMORRHAGE | RESPIRATORY SYSTEM | CRITICAL CARE MEDICINE | Lung Diseases, Interstitial - etiology | Lung Diseases, Interstitial - immunology | Lung - pathology | Lung Diseases, Interstitial - diagnosis | Biopsy | Humans | Female | Tomography, X-Ray Computed | Aged | Lung - diagnostic imaging | Pemphigoid, Bullous - complications | Pemphigoid, Bullous - immunology | Case studies | Complications and side effects | Development and progression | Care and treatment | Pulmonary fibrosis | Bullous pemphigoid
Pulmonary/Respiratory | LUNG | HEMORRHAGE | RESPIRATORY SYSTEM | CRITICAL CARE MEDICINE | Lung Diseases, Interstitial - etiology | Lung Diseases, Interstitial - immunology | Lung - pathology | Lung Diseases, Interstitial - diagnosis | Biopsy | Humans | Female | Tomography, X-Ray Computed | Aged | Lung - diagnostic imaging | Pemphigoid, Bullous - complications | Pemphigoid, Bullous - immunology | Case studies | Complications and side effects | Development and progression | Care and treatment | Pulmonary fibrosis | Bullous pemphigoid
Journal Article
Journal of Shoulder and Elbow Surgery, ISSN 1058-2746, 2015, Volume 24, Issue 5, pp. 809 - 813
Hypothesis and background Humeral retroversion is defined as the orientation of the humeral head relative to the distal humerus. Because none of the previous...
Orthopedics | computed tomography | three-dimensional measurement | baseball players | cylinder fitting | reliability | Humeral retroversion | Cylinder fitting | Computed tomography | Three-dimensional measurement | Reliability | Baseball players | ROTATION | SURGERY | SPORT SCIENCES | TORSION | PROXIMAL ULNA | ELBOW | THROWING SHOULDER | PROFESSIONAL BASEBALL PITCHERS | PLAYERS | MOTION | POSTERIOR CAPSULE THICKNESS | ORTHOPEDICS | HEAD RETROVERSION | Young Adult | Reproducibility of Results | Baseball | Computer Simulation | Humans | Male | Tomography, X-Ray Computed | Bone Retroversion - diagnostic imaging | Humerus - diagnostic imaging | Humeral Head - diagnostic imaging | Imaging, Three-Dimensional | Anatomic Landmarks
Orthopedics | computed tomography | three-dimensional measurement | baseball players | cylinder fitting | reliability | Humeral retroversion | Cylinder fitting | Computed tomography | Three-dimensional measurement | Reliability | Baseball players | ROTATION | SURGERY | SPORT SCIENCES | TORSION | PROXIMAL ULNA | ELBOW | THROWING SHOULDER | PROFESSIONAL BASEBALL PITCHERS | PLAYERS | MOTION | POSTERIOR CAPSULE THICKNESS | ORTHOPEDICS | HEAD RETROVERSION | Young Adult | Reproducibility of Results | Baseball | Computer Simulation | Humans | Male | Tomography, X-Ray Computed | Bone Retroversion - diagnostic imaging | Humerus - diagnostic imaging | Humeral Head - diagnostic imaging | Imaging, Three-Dimensional | Anatomic Landmarks
Journal Article
Chest, ISSN 0012-3692, 2011, Volume 140, Issue 4, pp. 235A - 235A
Journal Article
Neuroradiology, ISSN 0028-3940, 8/2017, Volume 59, Issue 8, pp. 759 - 769
We investigated whether diffusion kurtosis imaging (DKI) and quantitative susceptibility mapping (QSM) could detect pathological changes that occur in...
Neurology | Neurosciences | Medicine & Public Health | Diffusion kurtosis imaging | Multiple system atrophy | Progressive supranuclear palsy syndrome | Quantitative susceptibility mapping | Neurosurgery | Imaging / Radiology | Neuroradiology | Parkinson’s disease | Parkinson's disease | WORK-UP | PATHOLOGY | IRON DEPOSITION | VARIANT | NEUROIMAGING | CLINICAL NEUROLOGY | ACCURACY | DISEASE | 3T BRAIN MRI | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | GRAY-MATTER | PROGRESSIVE SUPRANUCLEAR PALSY | Diagnosis, Differential | Prospective Studies | Humans | Middle Aged | Image Interpretation, Computer-Assisted | Male | Brain Mapping - methods | Case-Control Studies | Anisotropy | Sensitivity and Specificity | Parkinsonian Disorders - diagnostic imaging | Aged, 80 and over | Female | Supranuclear Palsy, Progressive - diagnostic imaging | Aged | Diffusion Magnetic Resonance Imaging - methods | Multiple System Atrophy - diagnostic imaging | Usage | Diagnostic imaging | Diagnosis | Cerebellum | Basal ganglia | Mesencephalon | Change detection | Parkinsons disease | Mapping | Kurtosis | Medical diagnosis | Magnetic susceptibility | Atrophy | Ataxia | Differential diagnosis | Paralysis | Tegmentum | Diffusion | Movement disorders | Medical imaging | Neurodegenerative diseases | Cerebellar ataxia | Globus pallidus | Central nervous system diseases | Patients | Putamen | Magnetic resonance imaging | Progressive supranuclear palsy | Magnetic permeability | Gene mapping
Neurology | Neurosciences | Medicine & Public Health | Diffusion kurtosis imaging | Multiple system atrophy | Progressive supranuclear palsy syndrome | Quantitative susceptibility mapping | Neurosurgery | Imaging / Radiology | Neuroradiology | Parkinson’s disease | Parkinson's disease | WORK-UP | PATHOLOGY | IRON DEPOSITION | VARIANT | NEUROIMAGING | CLINICAL NEUROLOGY | ACCURACY | DISEASE | 3T BRAIN MRI | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | GRAY-MATTER | PROGRESSIVE SUPRANUCLEAR PALSY | Diagnosis, Differential | Prospective Studies | Humans | Middle Aged | Image Interpretation, Computer-Assisted | Male | Brain Mapping - methods | Case-Control Studies | Anisotropy | Sensitivity and Specificity | Parkinsonian Disorders - diagnostic imaging | Aged, 80 and over | Female | Supranuclear Palsy, Progressive - diagnostic imaging | Aged | Diffusion Magnetic Resonance Imaging - methods | Multiple System Atrophy - diagnostic imaging | Usage | Diagnostic imaging | Diagnosis | Cerebellum | Basal ganglia | Mesencephalon | Change detection | Parkinsons disease | Mapping | Kurtosis | Medical diagnosis | Magnetic susceptibility | Atrophy | Ataxia | Differential diagnosis | Paralysis | Tegmentum | Diffusion | Movement disorders | Medical imaging | Neurodegenerative diseases | Cerebellar ataxia | Globus pallidus | Central nervous system diseases | Patients | Putamen | Magnetic resonance imaging | Progressive supranuclear palsy | Magnetic permeability | Gene mapping
Journal Article
Journal of Cardiovascular Pharmacology, ISSN 0160-2446, 07/2016, Volume 68, Issue 1, pp. 58 - 66
BACKGROUND:Antiarrhythmic drugs (AAD) are often used for fatal ventricular arrhythmias during cardiopulmonary resuscitation (CPR). However, the efficacy of...
favorable neurological outcome | antiarrhythmic drugs | refractory ventricular tachycardia/fibrillation | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-ASSOCIATION GUIDELINES | INTRAVENOUS AMIODARONE | EFFICACY | VENTRICULAR-FIBRILLATION | HOSPITAL CARDIAC-ARREST | PUBLIC-ACCESS DEFIBRILLATION | NIFEKALANT HYDROCHLORIDE | LIDOCAINE | PHARMACOLOGY & PHARMACY | OUTCOMES | EPINEPHRINE | Cardiopulmonary Resuscitation - methods | Shock, Cardiogenic - therapy | Ventricular Fibrillation - diagnosis | Humans | Middle Aged | Shock, Cardiogenic - mortality | Male | Out-of-Hospital Cardiac Arrest - mortality | Out-of-Hospital Cardiac Arrest - physiopathology | Shock, Cardiogenic - physiopathology | Recovery of Function | Out-of-Hospital Cardiac Arrest - therapy | Time Factors | Ventricular Fibrillation - physiopathology | Female | Retrospective Studies | Odds Ratio | Tachycardia, Ventricular - therapy | Cardiopulmonary Resuscitation - adverse effects | Shock, Cardiogenic - diagnosis | Drug Administration Schedule | Japan | Risk Factors | Ventricular Fibrillation - mortality | Logistic Models | Treatment Outcome | Out-of-Hospital Cardiac Arrest - diagnosis | Chi-Square Distribution | Anti-Arrhythmia Agents - administration & dosage | Propensity Score | Tachycardia, Ventricular - physiopathology | Neurologic Examination | Tachycardia, Ventricular - mortality | Anti-Arrhythmia Agents - adverse effects | Tachycardia, Ventricular - diagnosis | Aged | Ventricular Fibrillation - therapy | Cardiopulmonary Resuscitation - mortality
favorable neurological outcome | antiarrhythmic drugs | refractory ventricular tachycardia/fibrillation | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-ASSOCIATION GUIDELINES | INTRAVENOUS AMIODARONE | EFFICACY | VENTRICULAR-FIBRILLATION | HOSPITAL CARDIAC-ARREST | PUBLIC-ACCESS DEFIBRILLATION | NIFEKALANT HYDROCHLORIDE | LIDOCAINE | PHARMACOLOGY & PHARMACY | OUTCOMES | EPINEPHRINE | Cardiopulmonary Resuscitation - methods | Shock, Cardiogenic - therapy | Ventricular Fibrillation - diagnosis | Humans | Middle Aged | Shock, Cardiogenic - mortality | Male | Out-of-Hospital Cardiac Arrest - mortality | Out-of-Hospital Cardiac Arrest - physiopathology | Shock, Cardiogenic - physiopathology | Recovery of Function | Out-of-Hospital Cardiac Arrest - therapy | Time Factors | Ventricular Fibrillation - physiopathology | Female | Retrospective Studies | Odds Ratio | Tachycardia, Ventricular - therapy | Cardiopulmonary Resuscitation - adverse effects | Shock, Cardiogenic - diagnosis | Drug Administration Schedule | Japan | Risk Factors | Ventricular Fibrillation - mortality | Logistic Models | Treatment Outcome | Out-of-Hospital Cardiac Arrest - diagnosis | Chi-Square Distribution | Anti-Arrhythmia Agents - administration & dosage | Propensity Score | Tachycardia, Ventricular - physiopathology | Neurologic Examination | Tachycardia, Ventricular - mortality | Anti-Arrhythmia Agents - adverse effects | Tachycardia, Ventricular - diagnosis | Aged | Ventricular Fibrillation - therapy | Cardiopulmonary Resuscitation - mortality
Journal Article
2000, ISBN 9784431702498, xvi, 455
Book
Clinical Immunology, ISSN 1521-6616, 2016, Volume 179, pp. 17 - 24
Abstract Kawasaki disease (KD) is a paediatric vasculitis whose pathogenesis remains unclear. Based on experimental studies using a mouse model for KD, we...
Allergy and Immunology | Kawasaki disease | Vasculitis | IP-10 | Pyk2 | ACTIVATION | IFN-GAMMA | ZONE B-CELLS | IMMUNOLOGY | MURINE MODEL | VASA VASORUM | CANDIDA-ALBICANS | INFLAMMATION | MOUSE MODEL | GENE-EXPRESSION | MICE | Candida albicans | Chemokine CXCL10 - blood | Mucocutaneous Lymph Node Syndrome - metabolism | Chemokine CXCL9 - blood | Aorta - metabolism | Tenascin - metabolism | Coronary Vessels - metabolism | Mice, Knockout | Focal Adhesion Kinase 2 - genetics | Macrophages - metabolism | Animals | STAT3 Transcription Factor - metabolism | Disease Models, Animal | Mucocutaneous Lymph Node Syndrome - blood | Tyrosine | Phenols | Proline | Health aspects | Analysis | Medical colleges | Cardiovascular agents
Allergy and Immunology | Kawasaki disease | Vasculitis | IP-10 | Pyk2 | ACTIVATION | IFN-GAMMA | ZONE B-CELLS | IMMUNOLOGY | MURINE MODEL | VASA VASORUM | CANDIDA-ALBICANS | INFLAMMATION | MOUSE MODEL | GENE-EXPRESSION | MICE | Candida albicans | Chemokine CXCL10 - blood | Mucocutaneous Lymph Node Syndrome - metabolism | Chemokine CXCL9 - blood | Aorta - metabolism | Tenascin - metabolism | Coronary Vessels - metabolism | Mice, Knockout | Focal Adhesion Kinase 2 - genetics | Macrophages - metabolism | Animals | STAT3 Transcription Factor - metabolism | Disease Models, Animal | Mucocutaneous Lymph Node Syndrome - blood | Tyrosine | Phenols | Proline | Health aspects | Analysis | Medical colleges | Cardiovascular agents
Journal Article
1982, Shinpan., Yūhikaku sōsho. Nyūmon kiso chishiki hen, ISBN 9784641097537, 8, 321
Book
Neurourology and Urodynamics, ISSN 0733-2467, 11/2019, Volume 38, Issue 8, pp. 2324 - 2332
Aim The objective of this study is to assess the association of muscle mass, grip strength, and gait speed with overactive bladder (OAB) in community‐dwelling...
muscle mass | frailty | grip strength | urgency | urinary incontinence | body mass index | Urinary incontinence | Analysis | Aged | Gait | Body mass index | Geriatrics
muscle mass | frailty | grip strength | urgency | urinary incontinence | body mass index | Urinary incontinence | Analysis | Aged | Gait | Body mass index | Geriatrics
Journal Article
ACTA NEUROCHIRURGICA, ISSN 0001-6268, 06/2019, Volume 161, Issue 6, pp. 1175 - 1181
BackgroundThe most frequent neurological complication during coil embolization of a ruptured cerebral aneurysm is a thromboembolic event. The association...
Coil embolization | SURGERY | THERAPY | Internal carotid artery | Aneurysm | ENDOVASCULAR TREATMENT | PREVENTION | RISK | Extracranial | MICROEMBOLI | CLINICAL NEUROLOGY | CEREBRAL ANEURYSMS | Coils | Cardiovascular system | Domes | Tortuosity | Complications | Aneurysms | Aspect ratio | Patients | Carotid arteries | Coiling | Embolization | Neck | Carotid artery | Thromboembolism | Health risk assessment | Curvature | Circulation
Coil embolization | SURGERY | THERAPY | Internal carotid artery | Aneurysm | ENDOVASCULAR TREATMENT | PREVENTION | RISK | Extracranial | MICROEMBOLI | CLINICAL NEUROLOGY | CEREBRAL ANEURYSMS | Coils | Cardiovascular system | Domes | Tortuosity | Complications | Aneurysms | Aspect ratio | Patients | Carotid arteries | Coiling | Embolization | Neck | Carotid artery | Thromboembolism | Health risk assessment | Curvature | Circulation
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 12646 - 17
Ocular dominance plasticity is easily observed during the critical period in early postnatal life. Chondroitin sulfate (CS) is the most abundant component in...
DENDRITIC SPINES | BRAIN PLASTICITY | OTX2 HOMEOPROTEIN | CORTICAL PLASTICITY | EXPERIENCE-DEPENDENT PLASTICITY | MULTIDISCIPLINARY SCIENCES | MOUSE | ENVIRONMENTAL ENRICHMENT | PERINEURONAL NETS | OCULAR DOMINANCE PLASTICITY | INTRACORTICAL INHIBITION | gamma-Aminobutyric Acid - genetics | Chondroitin Sulfates - genetics | Chondroitin Sulfates - metabolism | Visual Cortex - growth & development | Diazepam - administration & dosage | gamma-Aminobutyric Acid - metabolism | Embryonic Development - genetics | Aggrecans - genetics | Mice, Knockout | Neuronal Plasticity - genetics | Visual Cortex - pathology | Animals | Interneurons - metabolism | Otx Transcription Factors - genetics | N-Acetylgalactosaminyltransferases - genetics | Parvalbumins - genetics | Protein Binding | Visual Cortex - metabolism | Embryonic Development - drug effects | Dominance, Ocular - genetics | Neuroimaging | Interneurons | Dominance | Cortex (visual) | Parvalbumin | γ-Aminobutyric acid | Ocular dominance | Plasticity (visual) | Otx2 protein | Chondroitin sulfate | Perineuronal nets | Sulfate | Aggrecan | Critical period | Diazepam
DENDRITIC SPINES | BRAIN PLASTICITY | OTX2 HOMEOPROTEIN | CORTICAL PLASTICITY | EXPERIENCE-DEPENDENT PLASTICITY | MULTIDISCIPLINARY SCIENCES | MOUSE | ENVIRONMENTAL ENRICHMENT | PERINEURONAL NETS | OCULAR DOMINANCE PLASTICITY | INTRACORTICAL INHIBITION | gamma-Aminobutyric Acid - genetics | Chondroitin Sulfates - genetics | Chondroitin Sulfates - metabolism | Visual Cortex - growth & development | Diazepam - administration & dosage | gamma-Aminobutyric Acid - metabolism | Embryonic Development - genetics | Aggrecans - genetics | Mice, Knockout | Neuronal Plasticity - genetics | Visual Cortex - pathology | Animals | Interneurons - metabolism | Otx Transcription Factors - genetics | N-Acetylgalactosaminyltransferases - genetics | Parvalbumins - genetics | Protein Binding | Visual Cortex - metabolism | Embryonic Development - drug effects | Dominance, Ocular - genetics | Neuroimaging | Interneurons | Dominance | Cortex (visual) | Parvalbumin | γ-Aminobutyric acid | Ocular dominance | Plasticity (visual) | Otx2 protein | Chondroitin sulfate | Perineuronal nets | Sulfate | Aggrecan | Critical period | Diazepam
Journal Article
Journal of the American Heart Association, ISSN 2047-9980, 10/2016, Volume 5, Issue 10, p. n/a
Background The extent to which angina is associated with future cardiovascular events in patients with coronary artery disease has long been debated. Methods...
cardiovascular events | coronary artery disease | angina | Cardiovascular events | Coronary artery disease | Angina | CARDIAC & CARDIOVASCULAR SYSTEMS | OUTPATIENTS | MYOCARDIAL-ISCHEMIA | RISK | SYMPTOMS | RATES | HEART-DISEASE | SOUL | PECTORIS | CLARIFY REGISTRY | CLINICAL-OUTCOMES | United States - epidemiology | Myocardial Infarction - epidemiology | Prognosis | Humans | Middle Aged | Proportional Hazards Models | Hospitalization - statistics & numerical data | Male | Case-Control Studies | Myocardial Revascularization - utilization | Angina, Stable - epidemiology | Cardiovascular Diseases - mortality | Female | Registries | Stroke - epidemiology | Aged | Coronary Artery Disease - epidemiology | Odds Ratio | Heart Failure - epidemiology
cardiovascular events | coronary artery disease | angina | Cardiovascular events | Coronary artery disease | Angina | CARDIAC & CARDIOVASCULAR SYSTEMS | OUTPATIENTS | MYOCARDIAL-ISCHEMIA | RISK | SYMPTOMS | RATES | HEART-DISEASE | SOUL | PECTORIS | CLARIFY REGISTRY | CLINICAL-OUTCOMES | United States - epidemiology | Myocardial Infarction - epidemiology | Prognosis | Humans | Middle Aged | Proportional Hazards Models | Hospitalization - statistics & numerical data | Male | Case-Control Studies | Myocardial Revascularization - utilization | Angina, Stable - epidemiology | Cardiovascular Diseases - mortality | Female | Registries | Stroke - epidemiology | Aged | Coronary Artery Disease - epidemiology | Odds Ratio | Heart Failure - epidemiology
Journal Article